Expansions of tumor-reactive Vdelta1 gamma-delta T cells in newly diagnosed patients with chronic myeloid leukemia

por Knight, Andrea, Piskacek, Martin, Jurajda, Michal, Prochazkova, Jirina, Racil, Zdenek, Zackova, Daniela, Mayer, Jiri
Publicado 2022

The significance of enzyme and transporter polymorphisms for imatinib plasma levels and achieving an optimal response in chronic myeloid leukemia patients

por Belohlavkova, Petra, Vrbacky, Filip, Voglova, Jaroslava, Racil, Zdenek, Zackova, Daniela, Hrochova, Katerina, Malakova, Jana, Mayer, Jiri, Zak, Pavel
Publicado 2018

Estimation of current cumulative incidence of leukaemia-free patients and current leukaemia-free survival in chronic myeloid leukaemia in the era of modern pharmacotherapy

por Pavlík, Tomáš, Janoušová, Eva, Pospíšil, Zdeněk, Mužík, Jan, Žáčková, Daniela, Ráčil, Zdeněk, Klamová, Hana, Cetkovský, Petr, Trněný, Marek, Mayer, Jiří, Dušek, Ladislav
Publicado 2011

Quantitative assessment of the CD26+ leukemic stem cell compartment in chronic myeloid leukemia: patient-subgroups, prognostic impact, and technical aspects

por Culen, Martin, Borsky, Marek, Nemethova, Veronika, Razga, Filip, Smejkal, Jiri, Jurcek, Tomas, Dvorakova, Dana, Zackova, Daniela, Weinbergerova, Barbora, Semerad, Lukas, Sadovnik, Irina, Eisenwort, Gregor, Herrmann, Harald, Valent, Peter, Mayer, Jiri, Racil, Zdenek
Publicado 2016

COVID-19 in Patients with Chronic Myeloid Leukemia: Poor Outcomes for Patients with Comorbidities, Older Age, Advanced Phase Disease, and Those from Low-Income Countries: An Update...

por Pagnano, Katia B, Kok, Chung Hoow, Mauro, Michael J., Cortes, Jorge E., Evans, Nicola, Jiang, Qian, Milojkovic, Dragana, Moiraghi, Beatriz, Nicolini, Franck E., Ongondi, Matilda, Zackova, Daniela, Rea, Delphine, Hughes, Timothy P.
Publicado 2021

A Risk Model for CML Patients with COVID-19: Importance of Molecular Response in the Context of Age, Comorbidities and Country Income

por Radich, Jerald P., Kok, Chung Hoow, Chelysheva, Ekaterina Yu., Cortes, Jorge E., Jiang, Qian, Mauro, Michael, Milojkovic, Dragana, Moiraghi, Beatriz, Nicolini, Franck E., Ongondi, Matilda, Pagnano, Katia B, Žácková, Daniela, Rea, Delphine, Evans, Nicola, Hughes, Timothy
Publicado 2022

Molecular status 36 months after TKI discontinuation in CML is highly predictive for subsequent loss of MMR—final report from AFTER-SKI

por Richter, Johan, Lübking, Anna, Söderlund, Stina, Lotfi, Kourosh, Markevärn, Berit, Själander, Anders, Stenke, Leif, Deneberg, Stefan, Ahlstrand, Erik, Myhr-Eriksson, Kristina, Panayiotidis, Panayiotis, Gedde-Dahl, Tobias, Žáčková, Daniela, Mayer, Jiří, Olsson-Strömberg, Ulla, Mahon, Francois-Xavier, Saussele, Susanne, Hjorth-Hansen, Henrik, Koskenvesa, Perttu
Publicado 2021

P669: ANALYSIS OF FACTORS INFLUENCING THE DECISION TO STOP TKI TREATMENT IN CML PATIENTS IN DEEP MOLECULAR RESPONSE

por Semerad, Lukas, Žáčková, Daniela, Belohlavkova, Petra, Voglova, Jaroslava, Žák, Pavel, Faber, Edgar, Papajik, Tomas, Skoumalova, Ivana, Karas, Michal, Jindra, Pavel, Klamová, Hana, Salek, Cyril, Srbová, Dana, Zizkova, Hana, Stejskal, Lukas, Cerna, Olga, Cmunt, Eduard, Cicatkova, Petra, Kvetkova, Anezka, Hornak, Tomas, Jeziskova, Ivana, Jurcek, Tomas, Weinbergerová, Barbora, Prochazkova, Jirina, Machova Polakova, Katerina, Svobodnik, Adam, Stepanova, Radka, Mayer, Jiri
Publicado 2023

Evaluation of 5-year imatinib treatment of 458 patients with CP-CML in routine clinical practice and prognostic impact of different BCR-ABL cutoff levels

por Klamová, Hana, Poláková, Kateřina Machová, Mužík, Jan, Ráčil, Zdeněk, Žáčková, Daniela, Steinerová, Kateřina, Karas, Michal, Faber, Edgar, Demečková, Eva, Michalovičová-Sninská, Zuzana, Voglová, Jaroslava, Demitrovičová, Ľudmila, Mikušková, Eva, Tóthová, Elena, Chudej, Juraj, Markuljak, Imrich, Cmunt, Eduard, Moravcová, Jana, Dvořáková, Dana, Michalová, Kyra, Jarošová, Marie, Šťastná, Markéta Marková, Cetkovský, Petr, DuŠek, Ladislav, Koza, Vladimír, Trněný, Marek, Indrák, Karel
Publicado 2013

The EUTOS long-term survival (ELTS) score is superior to the Sokal score for predicting survival in chronic myeloid leukemia

por Pfirrmann, Markus, Clark, Richard E., Prejzner, Witold, Lauseker, Michael, Baccarani, Michele, Saussele, Susanne, Guilhot, François, Heibl, Sonja, Hehlmann, Rüdiger, Faber, Edgar, Turkina, Anna, Ossenkoppele, Gert, Höglund, Martin, Zaritskey, Andrey, Griskevicius, Laimonas, Olsson-Strömberg, Ulla, Everaus, Hele, Koskenvesa, Perttu, Labar, Boris, Sacha, Tomasz, Zackova, Daniela, Cervantes, Francisco, Colita, Adriana, Zupan, Irena, Bogdanovic, Andrija, Castagnetti, Fausto, Guilhot, Joëlle, Hasford, Joerg, Hochhaus, Andreas, Hoffmann, Verena S.
Publicado 2020

Impact of BCR::ABL1 transcript type on RT-qPCR amplification performance and molecular response to therapy

por Salmon, Matthew, White, Helen E., Zizkova, Hana, Gottschalk, Andrea, Motlova, Eliska, Cerveira, Nuno, Colomer, Dolors, Coriu, Daniel, Franke, Georg N., Gottardi, Enrico, Izzo, Barbara, Jurcek, Tomas, Lion, Thomas, Schäfer, Vivien, Venturi, Claudia, Vigneri, Paolo, Zawada, Magdalena, Zuna, Jan, Hovorkova, Lenka, Koblihova, Jitka, Klamova, Hana, Markova, Marketa Stastna, Srbova, Dana, Benesova, Adela, Polivkova, Vaclava, Zackova, Daniela, Mayer, Jiri, Roeder, Ingo, Glauche, Ingmar, Ernst, Thomas, Hochhaus, Andreas, Polakova, Katerina Machova, Cross, Nicholas C. P.
Publicado 2022